By: Michael Barbella
Trial seeks to validate the safety, efficacy of the NanoKnife System in treating targeted tumors while reducing or delaying the need for radical intervention.
Michael Barbella is a freelance writer specializing in the medical technology industry. With a focus on medical product outsourcing and orthopedic design, Michael's articles cover a wide range of topics including clinical trials, product advancements, industry collaborations, and executive appointments. His expertise and in-depth reporting provide valuable insights into the latest developments in the field.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Michael Barbella's work predominantly focuses on reporting press releases and private sector announcements related to medical devices, healthcare technology, clinical trials, FDA approvals, and medical research. He would likely be interested in receiving pitches concerning new product launches or updates within the healthcare and pharmaceutical industries.
Given his coverage attributes, Michael may respond well to pitches that involve exclusive data or insights from industry experts regarding advancements in medical devices or innovations in healthcare technology. Additionally, providing access to key opinion leaders or executives for interviews could also be an effective approach for reaching out to him.
Although no specific geographic focus is mentioned, it can be assumed that Michael covers global developments in the healthcare and pharmaceutical sectors due to the nature of the topics he reports on.
This information evolves through artificial intelligence and human feedback. Improve this profile .